The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $149,007 in first-year total cost, median $74,504.
Most frequent study sections
- Special Emphasis Panel[ZRG1 PSE-N (90)]1
- Vaccines Against Microbial Diseases Study Section[VMD]1
Most frequent institutions
- OHIO STATE UNIVERSITY1
- UNIVERSITY OF CALIFORNIA-IRVINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Development of a live attenuated vaccine for visceral leishmaniasis1R03AI144253-01 | SATOSKAR, ABHAY R | OHIO STATE UNIVERSITY, OH | $78,000 | VMD |
| 2019 | Vaccine Efficacy after a Sanitation Campaign: A Natural Experiment1R03AI135322-01 | BRUCKNER, TIM ALLEN | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $71,007 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.